Views & Analysis | Perspectives on pharma industry issues

Market Access

Two pills in the middle of multiple £1 coins

UK’s next pricing and access scheme to last for 7 years

Operational review meeting minutes released by the DHSC reveal industry and government are planning to move to a 7-year agreement.

Market Access

Magnifying glass over pills scattered over dollar and euro notes

One year after MFN: How US policy is reshaping the global ph...

Just over a year has passed since the Trump administration sent letters to 17 leading manufacturers demanding steps towards MFN pricing.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Patients

Breaking Bipolar I disorder stigma in the Hispanic community

For many Hispanic patients and families, that is where the gap between need and treatment can begin.

Digital

AI-native clinical research concept of HCP, clipboard, and AI capabilities overlain

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.

Articles

eyeforpharma Barcelona day one blog

As day one of the eyeforpharma Barcelona event takes place, Paul Tunnah provides regular updates, sponsored by IMS Health, on the sessions and issues discussed.

Articles

Pharma Gets Social: Eight years of Twitter for Pharma – from...

Daniel Ghinn explores the past eight years of Twitter use by the pharmaceutical industry in our digital and social media themed month. How has this relationship evolved? Read on...

Articles

#hashtagpharma: Pharma and the need for social media

Sofia Fionda debates, in pharmaphorum's digital and social media themed month, the opportunities that social media presents to pharma and how it can learn from brands like NIKE, which is embrac

Sales & Marketing

Why Klick Health, Oxford PharmaGenesis chose to join forces

Leadership from Klick Health and Oxford PharmaGenesis discuss their

Sales & Marketing

Are Insights leaders seeing real commercial value from AI ad...

Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.

Digital

Medtech's digital experience is ready for an upgrade

Medtech companies need to hold their software experience design to the same standard as the best digital products people use every day.

Digital

Building an AI-native CRO

Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.